Name | tert-butyl 4-[[6-[2-(quinoxaline-2-carbonylamino)phenyl]imidazo[2,1-b][1,3]thiazol-3-yl]methyl]piperazine-1-carboxylate |
---|
Molecular Formula | C30H31N7O3S |
---|---|
Molecular Weight | 569.67700 |
Exact Mass | 569.22100 |
PSA | 133.20000 |
LogP | 5.25980 |
HS Code | 2934100090 |
---|
~% 925436-46-0 |
Literature: Sirtris Pharmaceuticals, Inc. Patent: US2008/249103 A1, 2008 ; Location in patent: Page/Page column 35 ; US 20080249103 A1 |
Precursor 1 | |
---|---|
DownStream 1 | |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |